Formulary alignment: Use of formulary drug products is preferred; non-formulary or brand requests require demonstration that formulary products are contraindicated or have failed.
Based on Review Criteria items 1-3 (Formulary preferred; contraindication or trial/failure of formulary alternatives required).
Prior authorization conditions: A prior authorization (PA) is required for medications identified with PA restriction and for compounded medications; approval must be obtained before pharmacy coverage except when emergency supply protocol is used.
PA process: complete and fax the PA/Drug Exception Request form to MedImpact or call Customer Service for emergency supplies; see PA contact 888-274-9689 and Customer Service 888-327-0671.
Step therapy: If a step therapy edit applies, the member must have tried and failed the required formulary alternatives unless those alternatives are medically contraindicated; documentation of trial/failure or contraindication must be provided with the PA request to override the step edit.
ST edits define a sequence of medication alternatives; coverage for step-required medications is provided only after required alternatives have been tried and failed.
Review criteria applied to requests: The prescribing provider must document that (1) formulary drug products are contraindicated, (2) the patient has failed an appropriate trial of formulary or related agents, and (3) available formulary choices are not suited for the patient and the selected drug is required for patient safety (or use of a formulary product would be detrimental).
These items correspond to the policy's Review Criteria used when evaluating medication requests.
Provider documentation and submission: Providers must complete the Medication Request/Prior Authorization form including patient and prescriber information, requested drug (name, dose, strength), diagnosis (ICD-10 if known), quantity, length of treatment, reason for request, other medications tried/failed, and pertinent history; then fax to MedImpact at the numbers on the form or contact the PA phone number for assistance.
See Medication Request Form instructions and contact details on the PA form.
Exclusions and non-covered uses: Medications not listed on the Michigan Pharmaceutical Product List (MPPL), items designated as MDHHS Carve-Out (billed to Fee‑for‑Service Medicaid), medications for cosmetic or convenience purposes, experimental or unproven uses, cough and cold products, sexual enhancement/ED, fertility‑promoting drugs, and non‑FDA regulated medical foods are excluded from coverage.
Requests for excluded indications will be denied per non‑covered benefits policy.
Quantity limits and dose optimization: Medications are subject to quantity limits (QL) and dose optimization as listed on the MHP Medicaid Drug Formulary; PA requests must reflect compliance with applicable QLs or provide justification for exceptions.
Quantity limits may be specified per day, month, year, lifetime, or across a drug class.
Site of care and benefit scope: Drug benefit does not reimburse for drug products acquired for, or administered at, inpatient hospital, outpatient hospital, emergency room/clinic, or physician office/clinic when billed outside the pharmacy benefit; ensure PA and billing align with site-of-care rules.
Confirm appropriate billing route and site before submitting PA.